Stock Research for ACT

Current Price


Latest Update: 2017-12-15 15:54:00

$ 25.1805
$ 25.1805
$ 25.1805

Featured Broker: TradeStation

Get the due diligence for another stock.


ACT Stock Chart & Research Data

The ACT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ACT Due diligence Resources & Stock Charts

The ACT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACT Detailed Price Forecast - CNN Money CNN View ACT Detailed Summary - Google Finance
Yahoo View ACT Detailed Summary - Yahoo! Finance Zacks View ACT Stock Research & Analysis -

Stock Analysis

TradeIdeas View ACT Trends & Analysis - Trade-Ideas Barrons View ACT Major Holders - Barrons
NASDAQ View ACT Call Transcripts - NASDAQ Seeking View ACT Breaking News & Analysis - Seeking Alpha
Spotlight View ACT Annual Report - OTC Report View ACT OTC Short Report -
TradeKing View ACT Fundamentals - TradeKing Charts View ACT SEC Filings - Bar Chart
WSJ View Historical Prices for ACT - The WSJ Morningstar View Performance/Total Return for ACT - Morningstar
MarketWatch View the Analyst Estimates for ACT - MarketWatch CNBC View the Earnings History for ACT - CNBC
StockMarketWatch View the ACT Earnings - StockMarketWatch MacroAxis View ACT Buy or Sell Recommendations - MacroAxis
Bullish View the ACT Bullish Patterns - American Bulls Short Pains View ACT Short Pain Metrics -

Social Media Mentions

StockTwits View ACT Stock Mentions - StockTwits PennyStocks View ACT Stock Mentions - PennyStockTweets
Twitter View ACT Stock Mentions - Twitter Invest Hub View ACT Investment Forum News - Investor Hub
Yahoo View ACT Stock Mentions - Yahoo! Message Board Seeking Alpha View ACT Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ACT - Insider Cow View Insider Transactions for ACT - Insider Cow
CNBC View ACT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACT - OTC Markets
Yahoo View Insider Transactions for ACT - Yahoo! Finance NASDAQ View Institutional Holdings for ACT - NASDAQ

Stock Charts

FinViz View ACT Stock Insight & Charts - StockCharts View ACT Investment Charts -
BarChart View ACT Stock Overview & Charts - BarChart Trading View View ACT User Generated Charts - Trading View

Latest Financial News for ACT

Sin Is In With New Vice ETF
Posted on Wednesday December 13, 2017

AdvisorShares, an exchange traded fund provider known for its actively managed investment options, has launched a new ETF that capitalizes on vice and also one among the first to include targeted exposure ...

AdvisorShares Delivers Alcohol, Cannabis & Tobacco Exposure with New Actively Managed ETF
Posted on Monday December 11, 2017

BETHESDA, Md., Dec. 11, 2017 /PRNewswire/ -- AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), announced today that the AdvisorShares Vice ETF (Ticker: ACT) will begin trading on Tuesday, December 12, 2017. ACT becomes the first ETF – among both passively managed and actively managed strategies – that provides concentrated exposure to select companies associated with alcohol, cannabis and tobacco. ACT's portfolio management team carries extensive experience in the capital markets and a well-established expertise of investing in this area of the equity markets, which includes the founder and original portfolio manager of the Vice Fund mutual fund (VICEX).

Drugmaker Teva looks to sell Medis business to help cut debt
Posted on Wednesday August 09, 2017

Teva Pharmaceutical Industries , the world's largest generic drugmaker, said on Wednesday it was looking for a buyer for its Medis business as it sells assets to pare down its debt burden. Teva, which last week reported a drop in second-quarter results and cut its outlook and dividend, acquired Iceland-based Medis as part of its acquisition of Actavis last year. "Teva is looking at every opportunity to focus our business and streamline operations, processes and structure," Teva said in an emailed statement to Reuters.

UK Supreme Court rules in favor of Lilly's Alimta patents
Posted on Friday July 07, 2017

Eli Lilly and Co won a years-long patent dispute with Actavis on Friday after the UK Supreme Court ruled that the generic drugmaker's versions of Lilly's top-selling cancer drug Alimta directly infringe on certain Lilly patents in Britain, France, Italy and Spain. Teva Pharmaceutical Industries Ltd owns the generic versions of Alimta in question after buying Allergan Plc's generic business Actavis last August.

AdvisorShares Debuts 'Vice' ETF - Dec 13, 2017
However, Ahrens had previously managed a successful “vice” mutual fund, and the idea of something similar had been on AdvisorShares' radar for some time. “Once we really started to look at the numbers and thought about combining these things, it made ...

AdvisorShares issues new 'Vice' ETF: Fund Scan
Financial Planning - Dec 15, 2017
IndexIQ has launched an ETF to track large-cap U.S. equities that are expected to outperform the market. The IQ Chaikin U.S.
AdvisorShares Vice ETF shuns ESG - ETF Strategy

AdvisorShares Plans Vice ETF - Nov 17, 2017
A filing from AdvisorShares outlines the firm's plans to launch an actively managed ETF that will target companies involved in the tobacco, alcoholic beverage or marijuana industries.

AdvisorShares' First Vice ETF On The Way - Nov 24, 2017
In order to make the most of this trend, AdvisorShares plans to launch ETF on the NYSE Arca that target companies involved in the tobacco, alcoholic beverage or marijuana industries (read: Inside the Rise of Thematic ETFs).

Enter a stock symbol to view the stock details.